A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Clinical trial NCT06804811 · RECRUITING
Trial details
- NCT number
- NCT06804811
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-13
- Primary completion
- 2027-04-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.